These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 34118562

  • 21. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.
    Wolf J, Gerlach N, Weber K, Klima A, Wess G.
    Vet Clin Pathol; 2013 Jun; 42(2):196-206. PubMed ID: 23614733
    [Abstract] [Full Text] [Related]

  • 22. Inflammatory and immune variables as predictors of survival in dogs with myxomatous mitral valve disease.
    Cimerman M, Druzhaeva N, Nemec Svete A, Hajdinjak M, Pohar K, Ihan A, Domanjko Petrič A.
    BMC Vet Res; 2024 Sep 28; 20(1):431. PubMed ID: 39342325
    [Abstract] [Full Text] [Related]

  • 23. Plasma humanin as a prognostic biomarker for canine myxomatous mitral valve disease: a comparison with plasma NT-roBNP.
    Mangkhang K, Punyapornwithaya V, Tankaew P, Pongkan W, Chattipakorn N, Boonyapakorn C.
    Pol J Vet Sci; 2018 Dec 28; 21(4):673-680. PubMed ID: 30605282
    [Abstract] [Full Text] [Related]

  • 24. Incremental predictive value of echocardiographic indices of right ventricular function in the assessment of long-term prognosis in dogs with myxomatous mitral valve disease.
    Morita T, Nakamura K, Osuga T, Takiguchi M.
    J Vet Cardiol; 2022 Feb 28; 39():51-62. PubMed ID: 34979482
    [Abstract] [Full Text] [Related]

  • 25. Utility of focused cardiac ultrasonography training in veterinary students to differentiate stages of subclinical myxomatous mitral valve disease in dogs.
    Huh T, Achilles EJ, Massey LK, Loughran KA, Larouche-Lebel É, Convey V, McKaba VF, Crooks A, Kraus MS, Gelzer AR, Oyama MA.
    J Vet Intern Med; 2024 Feb 28; 38(3):1325-1333. PubMed ID: 38532734
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Plasma N-terminal protype-B natriuretic peptide and restrictive mitral flow to risk-stratify patients with stage B heart failure.
    Dini FL, Whalley G, Poppe K, Fontanive P, Rosa GM, Doughty RN, Di Bello V.
    Clin Cardiol; 2009 Dec 28; 32(12):711-7. PubMed ID: 20027664
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease.
    Hezzell MJ, Boswood A, Moonarmart W, Elliott J.
    J Vet Cardiol; 2012 Mar 28; 14(1):269-79. PubMed ID: 22366569
    [Abstract] [Full Text] [Related]

  • 34. Relationship of plasma N-terminal pro-brain natriuretic peptide concentrations to heart failure classification and cause of respiratory distress in dogs using a 2nd generation ELISA assay.
    Fox PR, Oyama MA, Hezzell MJ, Rush JE, Nguyenba TP, DeFrancesco TC, Lehmkuhl LB, Kellihan HB, Bulmer B, Gordon SG, Cunningham SM, MacGregor J, Stepien RL, Lefbom B, Adin D, Lamb K.
    J Vet Intern Med; 2015 Jan 28; 29(1):171-9. PubMed ID: 25308881
    [Abstract] [Full Text] [Related]

  • 35. Prognostic value of selected one-, two- and three-dimensional and Doppler echocardiographic methods to assess severity in dogs with myxomatous mitral valve disease.
    Tidholm A, Häggström J.
    J Vet Cardiol; 2022 Feb 28; 39():89-101. PubMed ID: 35008002
    [Abstract] [Full Text] [Related]

  • 36. Prediction of first onset of congestive heart failure in dogs with degenerative mitral valve disease: the PREDICT cohort study.
    Reynolds CA, Brown DC, Rush JE, Fox PR, Nguyenba TP, Lehmkuhl LB, Gordon SG, Kellihan HB, Stepien RL, Lefbom BK, Meier CK, Oyama MA.
    J Vet Cardiol; 2012 Mar 28; 14(1):193-202. PubMed ID: 22366568
    [Abstract] [Full Text] [Related]

  • 37. Prognostic value of left atrial stiffness estimated using echocardiography in dogs with myxomatous mitral valve disease.
    Osuga T, Kuroda K, Morita T, Sasaki N, Nakamura K, Takiguchi M.
    J Vet Cardiol; 2023 Feb 28; 45():15-26. PubMed ID: 36608614
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Diagnostic Value of Selected Echocardiographic Variables to Identify Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease.
    Tidholm A, Höglund K, Häggström J, Ljungvall I.
    J Vet Intern Med; 2015 Feb 28; 29(6):1510-7. PubMed ID: 26365438
    [Abstract] [Full Text] [Related]

  • 40. Predictive value of natriuretic peptides in dogs with mitral valve disease.
    Tarnow I, Olsen LH, Kvart C, Hoglund K, Moesgaard SG, Kamstrup TS, Pedersen HD, Häggström J.
    Vet J; 2009 May 28; 180(2):195-201. PubMed ID: 18675567
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.